Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS.

NCT02323724 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT02323724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02323724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS.
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Completed
Start date
February 28, 2015
Completion date
July 31, 2015
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

papillary thyroid carcinoma